Inhibition of PARP7 by RBN-2397 Activates the Type I Interferon Response in Tumors Leading to Robust Antitumor Activity

Time: 9:00 am
day: Day One


  • Explore how PARP7 negatively regulates the type 1 interferon response in cancer cells
  • Delving into discovery, development, and clinical progress of its inhibiton which triggers antitumor immunity